account_id none on file
legal_name Exagen Inc.
ticker XGN
cik 1274737
domain exagen.com
linkedin_company_url https://www.linkedin.com/company/exageninc/
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
hq Vista, CA, United States
sector index/company/sector/health-care/
calls 1 filings 0 executives 2 family 0
why_nownone on file
calls
From our standpoint, we just We believe our current expense profile is sufficient to launch these new markers. There may be some additional conferences we attend. There may be some small advertisements that we do on relevant to the rheumatology community. But from our standpoint, there's not a huge need to have an outsized expenditure related to the launch of these products.
May 13, 2024 / receipt, needs a key / Kamal, CFO | earnings call 2024-05-13 | transcript 0292ae23-9719-4085-846e-a1156123cda9 | chars 33185-33562 | segment 34
filingsnone on file
executives
| John Ibali | CEO | - | receipt |
| Kamala Dowie | Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-03 | earnings call | scheduled | ir |
changes
| 2023-12-11 | Chief Business Officer, departed | sec_8k |
mcp_package_hint
slug exagen-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$